543 related articles for article (PubMed ID: 1531569)
1. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
2. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
Diaz JI; Edinger MG; Stoler M; Tubbs RR
Leuk Lymphoma; 1993 Jan; 9(1-2):85-90. PubMed ID: 8477206
[TBL] [Abstract][Full Text] [Related]
3. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.
Chaperot L; Delfau-Larue MH; Jacob MC; Molens JP; Roussel B; Agrawal S; Farcet JP; Gressin R; Sotto JJ; Bensa JC; Plumas J
Exp Hematol; 1999 Jul; 27(7):1185-93. PubMed ID: 10390194
[TBL] [Abstract][Full Text] [Related]
5. T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant clone.
Jacob MC; Piccinni MP; Bonnefoix T; Sotto MF; Couderc P; Bensa JC; Sotto JJ
Blood; 1990 Mar; 75(5):1154-62. PubMed ID: 2306520
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
[TBL] [Abstract][Full Text] [Related]
9. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients.
Amini RM; Enblad G; Sundström C; Glimelius B
Int J Cancer; 1997 May; 71(4):510-6. PubMed ID: 9178801
[TBL] [Abstract][Full Text] [Related]
10. Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.
Atanackovic D; Panse J; Schafhausen P; Faltz C; Bartels K; Boeters I; Hossfeld DK; Hegewisch-Becker S
Leuk Res; 2005 Sep; 29(9):1019-27. PubMed ID: 16038728
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD45RA+ T cells modulate allergen-induced interleukin 2 responsiveness in human lymphocytes.
Kawano Y; Noma T; Maeda K; Yata J
Clin Immunol Immunopathol; 1992 Mar; 62(3):327-35. PubMed ID: 1531787
[TBL] [Abstract][Full Text] [Related]
12. Incidence and histological features of bone marrow involvement in malignant lymphomas.
Lambertenghi-Deliliers G; Annaloro C; Soligo D; Oriani A; Pozzoli E; Quirici N; Luksch R; Polli EE
Ann Hematol; 1992 Aug; 65(2):61-5. PubMed ID: 1324741
[TBL] [Abstract][Full Text] [Related]
13. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP
J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885
[TBL] [Abstract][Full Text] [Related]
14. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience.
Wain SL; Braylan RC; Borowitz MJ
Cancer; 1987 Nov; 60(10):2403-11. PubMed ID: 3499212
[TBL] [Abstract][Full Text] [Related]
15. Pattern of malignant lymphoma in the United Arab Emirates--a histopathologic and immunologic study in 208 native patients.
Castella A; Joshi S; Raaschou T; Mason N
Acta Oncol; 2001; 40(5):660-4. PubMed ID: 11669341
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
17. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
Smith JL; Jones DB; Bell AJ; Wright DH
Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
[TBL] [Abstract][Full Text] [Related]
18. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese.
Nakagawa A; Nakamura S; Koshikawa T; Nakayama A; Nagasaka T; Motoori T; Kojima M; Hosomura Y; Ueda R; Mori S
Acta Pathol Jpn; 1993; 43(1-2):44-54. PubMed ID: 8465656
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.
Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA
Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
